Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
Go back to Moderna Adds Chief Operating Officer Role as Company Expands into Oncology| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 190.31 -13.15 (6.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $203.46 | 52 Week High | $0.52 | |||
| Open | $186.55 | 52 Week Low | $0.08 | |||
| Day High | $196.83 | P/E | N/A | |||
| Day Low | $184.58 | EPS | $-3.80 | |||
| Volume | 8,052,845 | |||||
